StockWatch
·

Piramal Pharma Ltd Q2 FY26 Results

PPLPHARMAQ2 FY26 Results
Filing
MetricValue ( Cr)Q1 FY26Q2 FY25
Revenue2.0K5.7%8.8%
Total Income2.1K5.9%8.4%
Expenditure2.2K2.8%1.4%
PBT-60.9737.5%159.3%
Net Profit-99.2221.4%539.2%
OPM7.76%1.17pp19.27pp
NPM-4.70%0.60pp4.93pp
EPS0.7521.0%341.2%
View full financials

Informational and educational content only. Not investment advice.